Avantor Performance Materials, Inc.
3477 Corporate Parkway
Suite #200
Center Valley
New Jersey
18034
United States
Tel: 855-AVANTOR (+1-855-282-6867)
Fax: 610-573-2610
Website: http://www.avantormaterials.com/
Email: info@avantormaterials.com
56 articles about Avantor Performance Materials, Inc.
-
Avantor® to Report Fourth Quarter and Full Year 2022 Earnings and Host Earnings Call on Friday, February 3, 2023
1/6/2023
Avantor, Inc. announced that it will release its fourth quarter and full year 2022 financial results before the market opens on Friday, February 3, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.
-
Avantor® Reports Third Quarter 2022 Results
10/28/2022
Avantor, Inc. reported financial results for the quarter ended September 30, 2022.
-
Avantor® to Host Third Quarter 2022 Earnings Call on Friday, October 28, 2022
9/29/2022
Avantor, Inc. announced that it will release its third quarter 2022 financial results before the market opens on Friday, October 28.
-
Avantor® Reports Second Quarter 2022 Results
7/28/2022
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, reported financial results for the quarter ended June 30, 2022.
-
Avantor® Names Kitty Sahin Executive Vice President, Strategy and Corporate Development
7/19/2022
Avantor, Inc. has appointed veteran strategy and M&A executive, Kitty Sahin, to the newly created role of EVP, Strategy and Corporate Development, effective immediately.
-
Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers
6/23/2022
Collaboration will support growth of emerging modalities by offering custom cGMP solutions to enhance process efficiency and accelerate speed-to-market.
-
Avantor® to Report First Quarter 2022 Results and Host Earnings Call on April 29, 2022
4/6/2022
Avantor, Inc. announced that it will release its financial results for the first quarter 2022 after the market closes on April 28, 2022.
-
Avantor® to Participate in Barclays Global Healthcare Conference 2022
3/1/2022
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the Barclays Global Healthcare Conference 2022 being held on Tuesday, March 15, 2022.
-
Avantor® Reports Fourth Quarter and Full-Year 2021 Results
2/3/2022
Avantor, Inc. today reported financial results for the fourth quarter and year ended December 31, 2021.
-
Avantor® to Host Virtual Investor Day
8/30/2021
Avantor, Inc. announced that it will host a virtual investor day on September 9, 2021 starting at 9:00 a.m. Eastern Daylight Time .
-
Avantor® Announces Date Change for Second Quarter 2021 Earnings Release and Conference Call
7/16/2021
Avantor, Inc. today announced that it has changed the date of its previously announced earnings release and conference call. The Company will now release its financial results for the second quarter 2021 after the market closes on Thursday, July 29, 2021, and will hold a conference call on Friday, July 30, 2021 to discuss the results at 7:30 a.m. Eastern Daylight Time.
-
Avantor® to Acquire Ritter GmbH and its Affiliates; Expands Proprietary Offering for Diagnostic and Drug Discovery Workflows
4/12/2021
- Ritter is a fast-growing, technology leader in high-precision consumables - Combines Ritter's liquid handling consumables platform for clinical diagnostic testing and life sciences research with Avantor's offerings for critical lab automation workflows and leading global customer channel
-
Avantor® to Participate at the Raymond James 42nd Annual Institutional Investor Conference
2/22/2021
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the Raymond James 42nd Annual Institutional Investor Conference on Monday, March 1 , 2021.
-
Avantor® Reports Fourth Quarter and Full-Year 2020 Results
2/3/2021
Business Highlights - Q4 revenue of $1.791 billion, up 17.5%; organic revenue growth of 14.9% - Q4 Adjusted EBITDA $319.9 million, expansion of 60 basis points - Q4 EPS of $0.06; adjusted EPS of $0.29, growth of 57.2% - Q4 operating cash flow $306 million; free cash flow $286 million, growth of 282% [03-February-2021]
-
Avantor® to Report Fourth Quarter and Full Year 2020 Earnings and Host Earnings Call on Wednesday, February 3, 2021
1/11/2021
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the fourth quarter and full year 2020 after the market closes on Wednesday, February 3
-
Avantor® to Present at the 39th Annual J.P. Morgan Healthcare Conference
12/14/2020
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the 39th Annual J.P. Morgan Healthcare Conference being held virtually on Monday, January 11 , 2021. Michael Stubblefield, Pres
-
Avantor® Announces Secondary Offering of 71,339,001 Shares of Common Stock
11/4/2020
Avantor, Inc. announced that certain of its stockholders, including an affiliate of New Mountain Capital, LLC, intend to offer for sale in an underwritten secondary offering 71,339,001 shares of common stock of the Company pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission.
-
Avantor® Discusses Cell & Gene Therapy Production Trends Through the Lens of COVID-19
11/2/2020
Avantor executives joined other industry leaders at virtual Cell & Gene Therapy Bioprocessing & Commercialization Conference Panels discussed critical topics including process efficiency and scaling solutions
-
Avantor® Announces Offering of Senior First Lien Notes
10/28/2020
Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today the commencement of a private offering of euro-denominated senior first lien notes (the "Notes") to be issued by its whol
-
Avantor® Announces Preliminary Third Quarter Unaudited Revenues
10/23/2020
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, provided preliminary unaudited revenue estimates for the third quarter ended September 30, 2020 , in conjunction with proposed debt refinancing tran